Publications

  1. Kamboj AK, Katzka DA, Vela MF, Yadlapati R, Ravi K. A practical approach to ineffective esophageal motility. Neurogastroenterol Motil. 2024 Sep; 36 (9):e14839 Epub 2024 June 04
    View PubMed
  2. Bach L, Vela MF. Esophagogastric Junction Outflow Obstruction (EGJOO): A Manometric Phenomenon or Clinically Impactful Problem. Curr Gastroenterol Rep. 2024 Jul; 26 (7):173-180 Epub 2024 Mar 28
    View PubMed
  3. Olmos JA, Pandolfino JE, Piskorz MM, Zamora N, Valdovinos Diaz MA, Remes Troche JM, Guzman M, Hani A, Valdovinos Garcia LR, Pitanga Lukashok H, Domingues G, Vesco E, Rivas MM, Ovalle LFP, Cisternas D, Vela MF. Latin American consensus on diagnosis of gastroesophageal reflux disease. Neurogastroenterol Motil. 2024 Mar; 36 (3):e14735 Epub 2024 Jan 15
    View PubMed
  4. Kamal AN, Kathpalia P, Leiman DA, Bredenoord AJ, Clarke JO, Gyawali CP, Katzka DA, Lazarescu A, Pandolfino JE, Penagini R, Roman S, Savarino E, Vela MF, Otaki F. Quality Indicator Development for the Approach to Ineffective Esophageal Motility: A Modified Delphi Study. J Clin Gastroenterol. 2024 Jan 15 [Epub ahead of print]
    View PubMed
  5. Kamal AN, Kathpalia P, Leiman DA, Bredenoord AJ, Clarke JO, Gyawali CP, Katzka DA, Lazarescu A, Pandolfino JE, Penagini R, Roman S, Savarino E, Vela MF, Otaki F. Quality indicator development for the approach to ineffective esophageal motility. Journal of Clinical Gastroenterology. 2024; 58 (10):975-80
  6. Chen JW, Khan A, Chokshi RV, Clarke JO, Fass R, Garza JM, Gupta M, Gyawali CP, Jain AS, Katz P, Konda V, Lazarescu A, Lynch KL, Schnoll-Sussman F, Spechler SJ, Vela MF, Yadlapati R, Schauer JM, Kahrilas PJ, Pandolfino JE, Carlson DA. Interrater Reliability of Functional Lumen Imaging Probe Panometry and High-Resolution Manometry for the Assessment of Esophageal Motility Disorders. Am J Gastroenterol. 2023 Aug 1; 118 (8):1334-1343 Epub 2023 Apr 11
    View PubMed
  7. Achalu S, Berry R, Zhuo J, Bredenoord AJ, Clarke JO, Fass R, Gyawali CP, Kahrilas PJ, Katzka DA, Massey BT, Penagini R, Roman S, Savarino E, Vela MF, Kamal AN. Development and modification of a dysphagia question prompt list to improve patient-physician communication: Incorporating both esophageal expert and patient perspectives. Neurogastroenterol Motil. 2023 Aug; 35 (8):e14600 Epub 2023 Apr 30
    View PubMed
  8. Chen JW, Vela MF, Peterson KA, Carlson DA. AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review. Clin Gastroenterol Hepatol. 2023 Jun; 21 (6):1414-1421.e3 Epub 2023 Apr 14
    View PubMed
  9. Snyder DL, Vela MF. Impact of opioids on esophageal motility. Neurogastroenterol Motil. 2023 May; 35 (5):e14587 Epub 2023 Apr 15
    View PubMed
  10. Yadlapati R, Gyawali CP, Carlson DA, Pandolfino JE, Fass R, Khan A, Lin H, Richter JE, Vela MF, Vaezi M, Clarke JO. Inter- and intra-rater agreement of interpretation of functional lumen imaging probe in healthy subjects. Neurogastroenterol Motil. 2023 Mar; 35 (3):e14505 Epub 2022 Dec 08
    View PubMed
  11. Zhuo J, Triadafilopoulos G, Bredenoord AJ, Clarke JO, Fass R, Gyawali CP, Hawn M, Hwang JH, Kahrilas PJ, Katzka DA, Low D, Massey BT, Patel D, Penagini R, Roman S, Savarino E, Smout AJ, Swanstrom L, Tatum R, Vela MF, Zaninotto G, Kamal AN. Development of a Preliminary Question Prompt List as a Communication Tool for Adults With Achalasia: A Modified Delphi Study. J Clin Gastroenterol. 2023 Feb 1; 57 (2):159-164 Epub 2023 Feb 01
    View PubMed
  12. Yadlapati R, Gawron AJ, Gyawali CP, Chen J, Clarke J, Fass R, Jain A, Lynch K, Khan A, Katz PO, Katzka DA, Richter J, Schnoll-Sussman F, Spechler SJ, Vaezi MF, Vela M, Pandolfino JE. Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements. Aliment Pharmacol Ther 2022 Oct; 56 (8):1274-1283 Epub 2022 Aug 16
    View PubMed
  13. Pannala R, Krishnan K, Watson RR, Vela MF, Abu Dayyeh BK, Bhatt A, Bhutani MS, Bucobo JC, Chandrasekhara V, Copland AP, Jirapinyo P, Kumta NA, Law RJ, Maple JT, Melson J, Parsi MA, Rahimi EF, Saumoy M, Sethi A, Trikudanathan G, Trindade AJ, Yang J, Lichtenstein DR. Devices for esophageal function testing. VideoGIE. 2022 Jan; 7 (1):1-20 Epub 2021 Oct 22
    View PubMed
  14. Pannala R, Krishnan K, Watson RR, Vela MF, Abu Dayyeh BK, Bhatt A, Bhutani MS, Bucobo JC, Chandrasekhara V, Copland AP, Jirapinyo P, Kumta NA, Law RJ, Maple JT, Melson J, Parsi MA, Rahimi EF, Saumoy M, Sethi A, Trikudanathan G, Trindade AJ, Yang J, Lichtenstein DR, (ASGE Technology Committee Chair). Devices for esophageal function testing. Gastrointest Endosc. 2022 Jan; 95 (1):27-29 Epub 2021 Oct 22
    View PubMed
  15. Parsa N, Vela MF. Current diagnosis of achalasia: beyond standard high-resolution manometry. Foregut. 2022; 2 (4):395-401
  16. Carlson DA, Gyawali CP, Khan A, Yadlapati R, Chen J, Chokshi RV, Clarke JO, Garza JM, Jain AS, Katz P, Konda V, Lynch K, Schnoll-Sussman FH, Spechler SJ, Vela MF, Prescott JE, Baumann AJ, Donnan EN, Kou W, Kahrilas PJ, Pandolfino JE. Classifying Esophageal Motility by FLIP Panometry: A Study of 722 Subjects With Manometry. Am J Gastroenterol. 2021 Dec 1; 116 (12):2357-2366
    View PubMed
  17. Gyawali CP, Tutuian R, Zerbib F, Rogers BD, Frazzoni M, Roman S, Savarino E, de Bortoli N, Vela MF, Sifrim D. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management. Gastroenterology. 2021 Nov; 161 (5):1412-1422 Epub 2021 July 14
    View PubMed
  18. Kamal AN, Kathpalia P, Otaki F, Bredenoord AJ, Castell DO, Clarke JO, Falk GW, Fass R, Prakash Gyawali C, Kahrilas PJ, Katz PO, Katzka DA, Pandolfino JE, Penagini R, Richter JE, Roman S, Savarino E, Triadafilopoulos G, Vaezi MF, Vela MF, Leiman DA. Development of quality indicators for the diagnosis and management of achalasia. Neurogastroenterol Motil. 2021 Oct; 33 (10):e14118 Epub 2021 Mar 15
    View PubMed
  19. Khan A, Yadlapati R, Gonlachanvit S, Katzka DA, Park MI, Vaezi M, Vela M, Pandolfino J. Chicago Classification update (version 4.0): Technical review on diagnostic criteria for achalasia. Neurogastroenterol Motil. 2021 Jul; 33 (7):e14182 Epub 2021 June 30
    View PubMed
  20. Rogers BD, Valdovinos LR, Crowell MD, Bell R, Vela MF, Gyawali CP. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation. Gut. 2021 Mar; 70 (3):450-455 Epub 2020 May 28
    View PubMed
  21. Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, Babaei A, Mittal RK, Rommel N, Savarino E, Sifrim D, Smout A, Vaezi MF, Zerbib F, Akiyama J, Bhatia S, Bor S, Carlson DA, Chen JW, Cisternas D, Cock C, Coss-Adame E, de Bortoli N, Defilippi C, Fass R, Ghoshal UC, Gonlachanvit S, Hani A, Hebbard GS, Wook Jung K, Katz P, Katzka DA, Khan A, Kohn GP, Lazarescu A, Lengliner J, Mittal SK, Omari T, Park MI, Penagini R, Pohl D, Richter JE, Serra J, Sweis R, Tack J, Tatum RP, Tutuian R, Vela MF, Wong RK, Wu JC, Xiao Y, Pandolfino JE. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0((c)). Neurogastroenterol Motil. 2021 Jan; 33 (1):e14058
    View PubMed
  22. Clarke JO, Ahuja NK, Chan WW, Gyawali CP, Horsley-Silva JL, Kamal AN, Vela MF, Xiao Y. Mucosal impedance for esophageal disease: evaluating the evidence. Ann N Y Acad Sci. 2020 Dec; 1481 (1):247-257 Epub 2020 June 26
    View PubMed
  23. Chan WW, Ahuja N, Fisichella PM, Gavini S, Rangan V, Vela MF. Extraesophageal syndrome of gastroesophageal reflux: relationships with lung disease and transplantation outcome. Ann N Y Acad Sci. 2020 Dec; 1482 (1):95-105 Epub 2020 Aug 17
    View PubMed
  24. Clarke JO, Ahuja NK, Fernandez-Becker NQ, Gregersen H, Kamal AN, Khan A, Lynch KL, Vela MF. The functional lumen imaging probe in gastrointestinal disorders: the past, present, and future. Ann N Y Acad Sci. 2020 Dec; 1482 (1):16-25 Epub 2020 Aug 19
    View PubMed
  25. Savarino E, di Pietro M, Bredenoord AJ, Carlson DA, Clarke JO, Khan A, Vela MF, Yadlapati R, Pohl D, Pandolfino JE, Roman S, Gyawali CP. Use of the Functional Lumen Imaging Probe in Clinical Esophagology. Am J Gastroenterol. 2020 Nov; 115 (11):1786-1796
    View PubMed
  26. Hernandez PV, Valdovinos LR, Horsley-Silva JL, Valdovinos MA, Crowell MD, Vela MF. Response to multiple rapid swallows shows impaired inhibitory pathways in distal esophageal spasm patients with and without concomitant esophagogastric junction outflow obstruction. Dis Esophagus. 2020 Oct 12; 33 (10)
    View PubMed
  27. Bayoumi M, Snyder D, Vela MF. Small Intestine Diverticula in Polycystic Kidney Disease. Clin Gastroenterol Hepatol. 2020 Oct; 18 (11):e129 Epub 2019 July 20
    View PubMed
  28. Miller AT, Matar R, Abu Dayyeh BK, Beran A, Vela MF, Lacy BE, Crowell MD, Geno DM, Lavey CJ, Katzka DA, Ravi K. Postobesity Surgery Esophageal Dysfunction: A Combined Cross-Sectional Prevalence Study and Retrospective Analysis. Am J Gastroenterol. 2020 Oct; 115 (10):1669-1680
    View PubMed
  29. Bayoumi M, Kahn A, Snyder DL, Menias CO, Vela MF. Severe Achalasia Causing Cor Pulmonale. Am J Gastroenterol. 2020 Aug; 115 (8):1159
    View PubMed
  30. Snyder DL, Valdovinos LR, Horsley-Silva J, Crowell MD, Valdovinos MA, Vela MF. Opioids Interfere With Deglutitive Inhibition Assessed by Response to Multiple Rapid Swallows During High-Resolution Esophageal Manometry. Am J Gastroenterol. 2020 Jul; 115 (7):1125-1128
    View PubMed
  31. Snyder DL, Vela MF. Opioid-induced esophageal dysfunction. Curr Opin Gastroenterol. 2020 Jul; 36 (4):344-350
    View PubMed
  32. Snyder DL, Valdovinos LR, Horsley-Silva J, Crowell MD, Valdovinos MA, Vela MF. Opioids Interfere With Deglutitive Inhibition Assessed by Response to Multiple Rapid Swallows During High-Resolution Esophageal Manometry. Am J Gastroenterol. 2020 May 18 [Epub ahead of print]
    View PubMed
  33. Carlson DA, Gyawali CP, Roman S, Vela M, Taft TH, Crowell MD, Ravi K, Triggs JR, Quader F, Prescott J, Lin FTJ, Mion F, Biasutto D, Keefer L, Kahrilas PJ, Pandolfino JE. Esophageal Hypervigilance and Visceral Anxiety Are Contributors to Symptom Severity Among Patients Evaluated With High-Resolution Esophageal Manometry. Am J Gastroenterol. 2020 Mar; 115 (3):367-375
    View PubMed
  34. Khashab MA, Vela MF, Thosani N, Agrawal D, Buxbaum JL, Abbas Fehmi SM, Fishman DS, Gurudu SR, Jamil LH, Jue TL, Kannadath BS, Law JK, Lee JK, Naveed M, Qumseya BJ, Sawhney MS, Yang J, Wani S. ASGE guideline on the management of achalasia. Gastrointest Endosc. 2020 Feb; 91 (2):213-227.e6 Epub 2019 Dec 13
    View PubMed
  35. Pauwels A, Boecxstaens V, Andrews CN, Attwood SE, Berrisford R, Bisschops R, Boeckxstaens GE, Bor S, Bredenoord AJ, Cicala M, Corsetti M, Fornari F, Gyawali CP, Hatlebakk J, Johnson SB, Lerut T, Lundell L, Mattioli S, Miwa H, Nafteux P, Omari T, Pandolfino J, Penagini R, Rice TW, Roelandt P, Rommel N, Savarino V, Sifrim D, Suzuki H, Tutuian R, Vanuytsel T, Vela MF, Watson DI, Zerbib F, Tack J. How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery). Gut. 2019 Nov; 68 (11):1928-1941 Epub 2019 Aug 02
    View PubMed
  36. Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE, Vela MF. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose. Am J Gastroenterol. 2019 Sep; 114 (9):1464-1469
    View PubMed
  37. Horsley-Silva JL, Umar SB, Vela MF, Griffing WL, Parish JM, DiBaise JK, Crowell MD. The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality. Dis Esophagus. 2019 May 1; 32 (5)
    View PubMed
  38. Siddiki HA, Lam-Himlin DM, Kahn A, Bandres MV, Burdick GE, Crowell MD, Pannala R, Ramirez FC, Vela MF, Fleischer DE. Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett's esophagus. Gastrointest Endosc. 2019 Apr; 89 (4):759-768 Epub 2018 Nov 14
    View PubMed
  39. Tangaroonsanti A, Lee AS, Vela MF, Crowell MD, Erasmus D, Keller C, Mallea J, Alvarez F, Almansa C, DeVault KR, Houghton LA. Unilateral Versus Bilateral Lung Transplantation: Do Different Esophageal Risk Factors Predict Chronic Allograft Failure? J Clin Gastroenterol. 2019 Apr; 53 (4):284-289
    View PubMed
  40. Kahn A, Al-Qaisi MT, Obeid RA, Katzka DA, Ravi KM, Ramirez FC, Crowell MD, Vela MF. Clinical features and long-term outcomes of lower esophageal sphincter-dependent and lower esophageal sphincter-independent jackhammer esophagus. Neurogastroenterol Motil. 2019 Feb; 31 (2):e13507 Epub 2018 Nov 15
    View PubMed
  41. Al-Qaisi MT, Kahn A, Crowell MD, Burdick GE, Vela MF, Ramirez FC. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice? Dis Esophagus. 2018 Dec 1; 31 (12)
    View PubMed
  42. Blevins CH, Dierkhising RA, Geno DM, Johnson ML, Vela MF, Ravi K, Iyer PG, Katzka DA. Obesity and GERD impair esophageal epithelial permeability through 2 distinct mechanisms. Neurogastroenterol Motil. 2018 Oct; 30 (10):e13403 Epub 2018 July 30
    View PubMed
  43. Kuo JR, Davis AD, Rodriguez EA, Vela MF, Heigh RI, Salomao MA, Gurudu SR. Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors. Case Rep Gastroenterol. 2018 Sep-Dec; 12 (3):704-708 Epub 2018 Nov 28
    View PubMed
  44. Zaninotto G, Bennett C, Boeckxstaens G, Costantini M, Ferguson MK, Pandolfino JE, Patti MG, Ribeiro U Jr, Richter J, Swanstrom L, Tack J, Triadafilopoulos G, Markar SR, Salvador R, Faccio L, Andreollo NA, Cecconello I, Costamagna G, da Rocha JRM, Hungness ES, Fisichella PM, Fuchs KH, Gockel I, Gurski R, Gyawali CP, Herbella FAM, Holloway RH, Hongo M, Jobe BA, Kahrilas PJ, Katzka DA, Dua KS, Liu D, Moonen A, Nasi A, Pasricha PJ, Penagini R, Perretta S, Sallum RAA, Sarnelli G, Savarino E, Schlottmann F, Sifrim D, Soper N, Tatum RP, Vaezi MF, van Herwaarden-Lindeboom M, Vanuytsel T, Vela MF, Watson DI, Zerbib F, Gittens S, Pontillo C, Vermigli S, Inama D, Low DE. The 2018 ISDE achalasia guidelines. Dis Esophagus. 2018 Sep 01; 31(9).
    View PubMed
  45. Yadlapati R, Vaezi MF, Vela MF, Spechler SJ, Shaheen NJ, Richter J, Lacy BE, Katzka D, Katz PO, Kahrilas PJ, Gyawali PC, Gerson L, Fass R, Castell DO, Craft J, Hillman L, Pandolfino JE. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018 Jul; 113 (7):980-986 Epub 2018 Apr 24
    View PubMed
  46. Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018 Jul; 67 (7):1351-1362 Epub 2018 Feb 03
    View PubMed
  47. Tangaroonsanti A, Vela MF, Crowell MD, DeVault KR, Houghton LA. Esophageal dysmotility according to Chicago classification v3.0 vs v2.0: Implications for association with reflux, bolus clearance, and allograft failure post-lung transplantation. Neurogastroenterol Motil. 2018 Jun; 30 (6):e13296 Epub 2018 Feb 07
    View PubMed
  48. Blevins CH, Iyer PG, Vela MF, Katzka DA. The Esophageal Epithelial Barrier in Health and Disease. Clin Gastroenterol Hepatol. 2018 May; 16 (5):608-617 Epub 2017 June 23
    View PubMed
  49. Kahn A, Al-Qaisi M, Kommineni VT, Callaway JK, Boroff ES, Burdick GE, Lam-Himlin DM, Temkit M, Vela MF, Ramirez FC. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia. Dis Esophagus. 2018 Apr 1; 31 (4)
    View PubMed
  50. Al-Qaisi MT, Siddiki HA, Crowell MD, Burdick GE, Fleischer DE, Ramirez FC, Vela MF. The clinical significance of hypercontractile peristalsis: comparison of high-resolution manometric features, demographics, symptom presentation, and response to therapy in patients with Jackhammer esophagus versus Nutcracker esophagus. Dis Esophagus. 2017 Dec 1; 30 (12):1-7
    View PubMed
  51. Yadlapati R, Keswani RN, Ciolino JD, Grande DP, Listernick ZI, Carlson DA, Castell DO, Dunbar KB, Gawron AJ, Gyawali CP, Katz PO, Katzka D, Lacy BE, Spechler SJ, Tatum R, Vela MF, Pandolfino JE. A System to Assess the Competency for Interpretation of Esophageal Manometry Identifies Variation in Learning Curves. Clin Gastroenterol Hepatol. 2017 Nov; 15 (11):1708-1714.e3 Epub 2016 July 27
    View PubMed
  52. Roman S, Gyawali CP, Savarino E, Yadlapati R, Zerbib F, Wu J, Vela M, Tutuian R, Tatum R, Sifrim D, Keller J, Fox M, Pandolfino JE, Bredenoord AJ, GERD consensus group. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017 Oct; 29 (10):1-15 Epub 2017 Mar 31
    View PubMed
  53. Vaezi MF, Pandolfino JE, Vela MF, Shaheen NJ. White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol 2017 Aug; 15 (8):1162-1172 Epub 2017 Mar 23
    View PubMed
  54. Tangaroonsanti A, Lee AS, Crowell MD, Vela MF, Jones DR, Erasmus D, Keller C, Mallea J, Alvarez F, Almansa C, DeVault KR, Houghton LA. Impaired Esophageal Motility and Clearance Post-Lung Transplant: Risk For Chronic Allograft Failure. Clin Transl Gastroenterol. 2017 Jun 29; 8 (6):e102 Epub 2017 June 29
    View PubMed
  55. Gyawali CP, Roman S, Bredenoord AJ, Fox M, Keller J, Pandolfino JE, Sifrim D, Tatum R, Yadlapati R, Savarino E, International GERD Consensus Working Group. Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group. Neurogastroenterol Motil. 2017 May 24;
    View PubMed
  56. Ravi K, Geno DM, Vela MF, Crowell MD, Katzka DA. Baseline impedance measured during high-resolution esophageal impedance manometry reliably discriminates GERD patients. Neurogastroenterol Motil. 2017 May; 29 (5) Epub 2016 Oct 24
    View PubMed
  57. Crowell MD, Umar SB, Griffing WL, DiBaise JK, Lacy BE, Vela MF. Esophageal Motor Abnormalities in Patients With Scleroderma: Heterogeneity, Risk Factors, and Effects on Quality of Life. Clin Gastroenterol Hepatol. 2017 Feb; 15 (2):207-213.e1 Epub 2016 Sept 06
    View PubMed
  58. Carlson DA, Crowell MD, Kimmel JN, Patel A, Gyawali CP, Hinchcliff M, Griffing WL, Pandolfino JE, Vela MF. Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis. Clin Gastroenterol Hepatol. 2016 Oct; 14 (10):1502-6 Epub 2016 Apr 05
    View PubMed
  59. Patti MG, Vela MF, Odell DD, Richter JE, Fisichella PM, Vaezi MF. The Intersection of GERD, Aspiration, and Lung Transplantation. J Laparoendosc Adv Surg Tech A. 2016 Jul; 26 (7):501-5 Epub 2016 May 24
    View PubMed
  60. Yadlapati R, Gawron AJ, Keswani RN, Bilimoria K, Castell DO, Dunbar KB, Gyawali CP, Jobe BA, Katz PO, Katzka DA, Lacy BE, Massey BT, Richter JE, Schnoll-Sussman F, Spechler SJ, Tatum R, Vela MF, Pandolfino JE. Identification of Quality Measures for Performance of and Interpretation of Data From Esophageal Manometry. Clin Gastroenterol Hepatol. 2016 Apr; 14 (4):526-534.e1 Epub 2015 Oct 20
    View PubMed
  61. Olmos JA, Piskorz MM, Vela MF. Gastroesophageal reflux disease review (GERD). Acta Gastroenterologica Latinoamericana. 2016; 46: (2)160-72.
  62. Shah SL, Lacy BE, DiBaise JK, Vela MF, Crowell MD. The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy. Aliment Pharmacol Ther. 2015 Nov; 42(9):1093-100. Epub 2015 Sep 08.
    View PubMed
  63. Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, Lacy BE, Murray JA. Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids. Am J Gastroenterol. 2015 Jul; 110 (7):979-84 Epub 2015 June 02
    View PubMed
  64. Yadlapati R, Gawron AJ, Bilimoria K, Keswani RN, Dunbar KB, Kahrilas PJ, Katz P, Richter J, Schnoll-Sussman F, Soper N, Vela MF, Pandolfino JE. Development of quality measures for the care of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2015 May; 13 (5):874-83.e2 Epub 2014 Nov 18
    View PubMed
  65. Nguyen T, Ramsey D, Graham D, Shaib Y, Shiota S, Velez M, Cole R, Anand B, Vela M, El-Serag HB. The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans. Helicobacter.2015;
  66. Vela MF. Diagnostic work-up of GERD. Gastrointest Endosc Clin N Am. 2014 Oct; 24 (4):655-66 Epub 2014 July 30
    View PubMed
  67. Vela MF. Management strategies for achalasia. Neurogastroenterol Motil. 2014 Sep; 26 (9):1215-21
    View PubMed
  68. de Mezerville Cantillo L, Cabas Sanchez J, Contreras F, Castellanos Garcia LF, Dondis JE, Galdamez J, Garcia-Maradiaga R, Grullon Dickson F, Jerez Gonzalez LE, Mayo DiBello M, Mejia Rivas MA, Moreno Padilla P, Sanchez Hernandez MA, Velasco SR, Vela MF, Valdovinos-Diaz MA, Remes-Troche JM. [Practice guideline of the Centroamerican and Carribean Association of Gastroenterology and Gastrointestinal Endoscopy for the management of gastroesophageal reflux disease]. Acta Gastroenterol Latinoam. 2014 Jun; 44(2):138-53.
    View PubMed
  69. Vela MF, Kramer JR, Richardson PA, Dodge R, El-Serag HB. Poor sleep quality and obstructive sleep apnea in patients with GERD and Barrett's esophagus. Neurogastroenterol Motil. 2014 Mar; 26(3):346-52. Epub 2013 Dec 09.
    View PubMed
  70. Vela MF. Medical treatments of GERD: the old and new. Gastroenterol Clin North Am. 2014 Mar; 43(1):121-33. Epub 2013 Dec 31.
    View PubMed
  71. Fischbach LA, Graham DY, Kramer JR, Rugge M, Verstovsek G, Parente P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Kolpachi A, Gupta S, Vela MF, Velez M, Cole R, Anand B, El Serag HB. Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol. 2014 Mar; 109(3):357-68. Epub 2014 Jan 14.
    View PubMed
  72. El-Serag HB, Hashmi A, Garcia J, Richardson P, Alsarraj A, Fitzgerald S, Vela M, Shaib Y, Abraham NS, Velez M, Cole R, Rodriguez MB, Anand B, Graham DY, Kramer JR. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut. 2014 Feb; 63(2):220-9. Epub 2013 Feb 13.
    View PubMed
  73. Richter JE, Pandolfino JE, Vela MF, Kahrilas PJ, Lacy BE, Ganz R, Dengler W, Oelschlager BK, Peters J, DeVault KR, Fass R, Gyawali CP, Conklin J, DeMeester T, Esophageal Diagnostic Working Group. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group. Dis Esophagus. 2013 Nov-Dec; 26 (8):755-65 Epub 2012 Aug 07
    View PubMed
  74. Jobe BA, Richter JE, Hoppo T, Peters JH, Bell R, Dengler WC, DeVault K, Fass R, Gyawali CP, Kahrilas PJ, Lacy BE, Pandolfino JE, Patti MG, Swanstrom LL, Kurian AA, Vela MF, Vaezi M, DeMeester TR. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg 2013 Oct; 217 (4):586-97 Epub 2013 Aug 21
    View PubMed
  75. Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013 Aug; 108(8):1238-49; quiz 1250. Epub 2013 Jul 23.
    View PubMed
  76. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar; 108(3):308-28; quiz 329. Epub 2013 Feb 19.
    View PubMed
  77. Villa N, Vela MF. Impedance-pH testing. Gastroenterol Clin North Am. 2013 Mar; 42(1):17-26.
    View PubMed
  78. Sealock RJ, Kramer JR, Verstovsek G, Richardson P, Rugge M, Parente P, Vela M, El-Serag HB. The prevalence of oesophageal eosinophilic and eosinophilic esophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther. 2013; 37:825-32.
  79. Bredenoord AJ, Fox M, Kahrilas PJ, Pandolfino JE, Schwizer W, Smout AJ, International High Resolution Manometry Working Group. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012 Mar; 24 Suppl 1: 57-65.
    View PubMed
  80. Remes-Troche JM, Ramirez-Cervantes KL, Vela MF. [If no-acid, no-heartburn? New physiopathological mechanisms of the gastroesophageal reflux disease]. Rev Gastroenterol Mex. 2011 Jul-Sep; 76(3):237-46.
    View PubMed
  81. Vela MF, Craft BM, Sharma N, Freeman J, Hazen-Martin D. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am J Gastroenterol. 2011 May; 106(5):844-50. Epub 2010 Dec 21.
    View PubMed
  82. Sharma P, Kozarek R, Practice Parameter Committee of the American College of Gastroenterology, Practice Parameters Committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol. 2010 Feb; 105: (2)258-73; quiz 274.
    View PubMed
  83. Blonski W, Vela MF, Castell DO. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol. 2009 Oct; 43(9):816-20.
    View PubMed
  84. Pandolfino JE, Vela MF. Esophageal-reflux monitoring. Gastrointest Endosc. 2009 Apr; 69(4):917-30, 930.e1. Epub 2009 Feb 26.
    View PubMed
  85. Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009 Mar; 43(3):253-60.
    View PubMed
  86. Vela MF. Non-acid reflux: detection by multichannel intraluminal impedance and pH, clinical significance and management. Am J Gastroenterol. 2009 Feb; 104(2):277-80.
    View PubMed
  87. Agrawal A, Roberts J, Sharma N, Tutuian R, Vela M, Castell DO. Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus. 2009; 22(5):467-70. Epub 2009 Feb 13.
    View PubMed
  88. Vela MF. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol. 2008 Oct; 2(5):665-72.
    View PubMed
  89. Blonski W, Hila A, Vela MF, Castell DO. An analysis of distal esophageal impedance in individuals with and without esophageal motility abnormalities. J Clin Gastroenterol. 2008 Aug; 42(7):776-81.
    View PubMed
  90. Wilson JA, Vela MF. New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance. Curr Gastroenterol Rep. 2008 Jun; 10(3):222-30.
    View PubMed
  91. Tutuian R, Vela MF, Hill EG, Mainie I, Agrawal A, Castell DO. Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol. 2008 May; 103(5):1090-6. Epub 2008 Apr 28.
    View PubMed
  92. Sharma N, Agrawal A, Freeman J, Vela MF, Castell D. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol. 2008 May; 6(5):521-4. Epub 2008 Mar 20.
    View PubMed
  93. Blonski W, Vela M, Safder A, Hila A, Castell DO. Revised criterion for diagnosis of ineffective esophageal motility is associated with more frequent dysphagia and greater bolus transit abnormalities. Am J Gastroenterol. 2008 Mar; 103(3):699-704.
    View PubMed
  94. Blonski W, Vela M, Hila A, Castell DO. Normal values for manometry performed with swallows of viscous test material. Scand J Gastroenterol. 2008; 43(2):155-60.
    View PubMed
  95. Sierra F, Suarez M, Rey M, Vela MF. Systematic review: Proton pump inhibitor-associated acute interstitial nephritis. Aliment Pharmacol Ther. 2007 Aug 15; 26(4):545-53.
    View PubMed
  96. Blonski W, Hila A, Jain V, Freeman J, Vela M, Castell DO. Impedance manometry with viscous test solution increases detection of esophageal function defects compared to liquid swallows. Scand J Gastroenterol. 2007 Aug; 42(8):917-22.
    View PubMed
  97. Vela MF. Can non-acid reflux cause heartburn? Current GERD Reports. 2007; 1:144-8.
  98. Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, Castell DO. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006 Oct; 55(10):1398-402. Epub 2006 Mar 23.
    View PubMed
  99. Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, Rice TW. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006 May; 4(5):580-7.
    View PubMed
  100. Guardino JM, Vela MF, Connor JT, Richter JE. Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol. 2004 Nov-Dec; 38(10):855-60.
    View PubMed
  101. Srinivasan R, Tutuian R, Schoenfeld P, Vela MF, Castell JA, Isaac T, Galaria I, Katz PO, Castell DO. Profile of GERD in the adult population of a northeast urban community. J Clin Gastroenterol. 2004 Sep; 38(8):651-7.
    View PubMed
  102. Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, Zhang X, Adhami T, Murray J, Peters J, Castell D. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: A multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004 Jun; 99(6):1037-43.
    View PubMed
  103. Vela MF, Richter JE, Wachsberger D, Connor J, Rice TW. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol. 2004 Jun; 99(6):1029-36.
    View PubMed
  104. Vela MF, Vaezi MF. Cost-assessment of alternative management strategies for achalasia. Expert Opin Pharmacother. 2003 Nov; 4(11):2019-25.
    View PubMed
  105. Tutuian R, Vela MF, Shay SS, Castell DO. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol. 2003 Sep; 37(3):206-15.
    View PubMed
  106. Tutuian R, Vela MF, Balaji NS, Wise JL, Murray JA, Peters JH, Shay SS, Castell DO. Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers. Clin Gastroenterol Hepatol. 2003 May; 1(3):174-82.
    View PubMed
  107. Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003 Jan; 17(2):243-51.
    View PubMed
  108. Castell DO, Vela M. Combined multichannel intraluminal impedance and pH-metry: an evolving technique to measure type and proximal extent of gastroesophageal reflux. Am J Med. 2001 Dec 3; 111 Suppl 8A:157S-159S.
    View PubMed
  109. Camacho-Lobato L, Katz PO, Eveland J, Vela M, Castell DO. Vigorous achalasia: original description requires minor change. J Clin Gastroenterol. 2001 Nov-Dec; 33(5):375-7.
    View PubMed
  110. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001 Jun; 120(7):1599-606.
    View PubMed
  111. Srinivasan R, Katz PO, Ramakrishnan A, Katzka DA, Vela MF, Castell DO. Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Aliment Pharmacol Ther. 2001 Apr; 15(4):519-24.
    View PubMed
  112. Srinivasan R, Vela MF, Katz PO, Tutuian R, Castell JA, Castell DO. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol. 2001 Mar; 280(3):G457-62.
    View PubMed
  113. Ramakrishnan A, Srinivasan R, Vela MF, Katz PO, Castell DO. Comparison of esophageal motility testing: results from university and community hospitals. Are standards for clinical practice needed? Practical Gastroenterol. 2000; 24:84-92.